Moderate intensity exercise prevents diabetic cardiomyopathy associated contractile dysfunction through restoration of mitochondrial function and connexin 43 levels in db/db mice

Journal of Molecular and Cellular Cardiology
Sudhakar VeerankiSuresh C Tyagi

Abstract

Although the cardiovascular benefits of exercise are well known, exercise induced effects and mechanisms in prevention of cardiomyopathy are less clear during obesity associated type-2 diabetes. The current study assessed the impact of moderate intensity exercise on diabetic cardiomyopathy by examining cardiac function and structure and mitochondrial function. Obese-diabetic (db/db), and lean control (db/+) mice, were subjected to a 5 week, 300 m run on a tread-mill for 5 days/week at the speeds of 10-11 m/min. Various physiological parameters were recorded and the heart function was evaluated with M-mode echocardiography. Contraction parameters and calcium transits were examined on isolated cardiomyocytes. At the molecular level: connexin 43 and 37 (Cx43 and 37) levels, mitochondrial biogenesis regulators: Mfn2 and Drp-1 levels, mitochondrial trans-membrane potential and cytochrome c leakage were assessed through western blotting immunohistochemistry and flow cytometry. Ability of exercise to reverse oxygen consumption rate (OCR), tissue ATP levels, and cardiac fibrosis were also determined. The exercise regimen was able to prevent diabetic cardiac functional deficiencies: ejection fraction (EF) and fractional shortening (FS)....Continue Reading

References

Mar 4, 2000·Circulation Research·S MiyataL A Leinwand
Apr 17, 2002·Circulation·Martin E YoungHeinrich Taegtmeyer
Oct 5, 2002·Circulation Research·Brian G PetrichYibin Wang
Mar 31, 2004·The American Journal of Cardiology·John K BoyerJulio E Pérez
Nov 24, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Patrick YuePhilip S Tsao
Apr 18, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Joel P FrenchScott K Powers
May 9, 2008·American Journal of Physiology. Cell Physiology·Ayako MakinoWolfgang H Dillmann
Jul 22, 2008·American Journal of Physiology. Heart and Circulatory Physiology·Farzad Moien-AfshariIsmail Laher
Sep 23, 2008·The International Journal of Biochemistry & Cell Biology·Xiuli MenJinning Lou
Oct 23, 2009·Circulation. Cardiovascular Imaging·Mikael Kjaer PoulsenJacob Eifer Møller
Feb 5, 2010·Investigative Ophthalmology & Visual Science·Michael W BobbieSayon Roy
Feb 25, 2010·Reviews in Endocrine & Metabolic Disorders·Sihem Boudina, Evan Dale Abel
Dec 15, 2010·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Hyo-Bum KwakJohn M Lawler
Dec 15, 2010·Journal of Cardiovascular Pharmacology·Sanne de JongJacques M T de Bakker
Feb 23, 2012·British Journal of Pharmacology·Aileen J F King
Jun 7, 2014·Canadian Journal of Physiology and Pharmacology·Srikanth GivvimaniSuresh C Tyagi
Oct 22, 2014·Circulation Research·Yoshiyuki IkedaJunichi Sadoshima
Apr 5, 2015·International Journal of Cardiology·S GivvimaniS C Tyagi
May 17, 2015·American Journal of Physiology. Heart and Circulatory Physiology·Sudhakar VeerankiSuresh C Tyagi
Jun 13, 2015·Molecular Biology of the Cell·Wutigri NimlamoolMatthias M Falk
Jul 16, 2015·Canadian Journal of Physiology and Pharmacology·Srikanth GivvimaniSuresh C Tyagi

❮ Previous
Next ❯

Citations

Jan 29, 2017·Redox Biology·Susana Rovira-LlopisVictor M Victor
Jun 25, 2017·Journal of Molecular and Cellular Cardiology·Fabian Sanchis-GomarCarme Perez-Quilis
Sep 18, 2018·Medicine and Science in Sports and Exercise·Chunlian MaY I Yang
Sep 22, 2017·Pharmacological Reviews·Luc LeybaertRainer Schulz
Dec 17, 2019·Acta Physiologica·Marina Makrecka-KukaTerje S Larsen
Feb 13, 2017·Cardiovascular Drugs and Therapy·Sang-Bing OngDerek John Hausenloy
Nov 9, 2018·Frontiers in Physiology·Nicolai M DolibaMary D Osbakken
Sep 7, 2019·Journal of Cellular Physiology·Akash K GeorgeSuresh C Tyagi
Apr 26, 2020·Apoptosis : an International Journal on Programmed Cell Death·Xianxian CaoCaixia Guo
Oct 17, 2017·Pflügers Archiv : European journal of physiology·Tae Hee KoJin Han
Dec 18, 2019·International Journal of Molecular Sciences·Dae Yun SeoJin Han
Dec 12, 2018·Frontiers in Physiology·Laurel A Grisanti
Jul 21, 2020·Canadian Journal of Physiology and Pharmacology·Hao-Xi ZhaoYongsheng Yu
Aug 23, 2020·Medicine and Science in Sports and Exercise·Shengcun LiSonghe Jiang
Apr 21, 2020·Endocrine, Metabolic & Immune Disorders Drug Targets·Abdelaziz M HusseinLashin S Lashin
Jan 5, 2021·Frontiers in Cell and Developmental Biology·Anqi LiGuohua Gong
Jan 11, 2020·Journal of Sport and Health Science·Shanshan GuoTiemin Liu
Dec 20, 2020·International Journal of Molecular Sciences·Yi Sun, Shuzhe Ding
Feb 15, 2021·Translational Research : the Journal of Laboratory and Clinical Medicine·Shlok JindalGopinath Packirisamy
Mar 1, 2021·The American Journal of Pathology·Rubens P HommeMahavir Singh
Sep 30, 2021·Journal of the American Heart Association·Phung N ThaiElena N Dedkova

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomegaly

Cardiomegaly, known as an enlarged heart, is a multifactorial disease with different pathophysiological mechanisms. Hypertension, pregnancy, exercise-induced and idiopathic causes are some mechanisms of cardiomegaly. Discover the latest research of cardiomegaly here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Calcium & Bioenergetics

Bioenergetic processes, including cellular respiration and photosynthesis, concern the transformation of energy by cells. Here is the latest research on the role of calcium in bioenergetics.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.